Kidney Diseases
291
37
60
145
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
31 trials with published results (11%)
Research Maturity
145 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
19 terminated out of 291 trials
88.4%
+1.8% vs benchmark
15%
45 trials in Phase 3/4
21%
31 of 145 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 145 completed trials
Clinical Trials (291)
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis
Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
The Effects of the CF Carrier State on the Kidneys and Pancreas
Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency
Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy
ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
SII and SIRI as Prognostic Biomarkers in Lupus Nephritis
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recontrast and Renal Outcomes in Patients With Pre-Existing Renal Dysfunction
Savolitinib vs. Sunitinib in MET-driven PRCC.
TESTING -ON Post-Trial ObservatioNal Cohort Study
Access to Kidney Transplantation in Minority Populations
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>